InsiderDB

Lobbying disclosures · Lobbying report

COR: third_quarter 2026 lobbying report

Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule)

Follow COR
Became public
Oct 15, 2026, 9:11 PM EDT
Event / period date
Not stated
Collected
Nov 11, 2026, 3:19 AM EST

Why this is connected

Exact legal-name match: Cencora, Inc. (https://www.sec.gov/Archives/edgar/data/1140859/).

Reported lobbying amounts

Income: $30,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/6ab06e32-c96a-47b3-8b52-cf91d826115f/","filing_uuid":"6ab06e32-c96a-47b3-8b52-cf91d826115f","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/6ab06e32-c96a-47b3-8b52-cf91d826115f/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael Tongour","dt_posted":"2026-10-15T21:11:37-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"4937 Tilden St NW","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20016","registrant":{"id":51478,"url":"https://lda.gov/api/v1/registrants/51478/","house_registrant_id":34927,"name":"TCH GROUP, LLC","description":"Government relations consulting firm","address_1":"4937 Tilden St NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20016","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL A. TONGOUR","contact_telephone":"+1 202-321-3579","dt_updated":"2026-07-18T07:44:30.034211-04:00"},"client":{"id":157457,"url":"https://lda.gov/api/v1/clients/157457/","client_id":1004517,"name":"CENCORA, INC.","general_description":"Pharmaceutical services company with a focus on the pharmaceutical supply chain.","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-08-03"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18004,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TONGOUR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5039,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"HOLSCLAW","suffix":null,"suffix_display":null},"covered_position":"Senate floor staff, Republican Secretary's office","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in COR

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.